International Cooperative Ataxia Rating Scale (ICARS): Appropriate for studies of Friedreich's ataxia?

Movement Disorders

Volumn 20, Issue 12, 2005, Pages 1585-1591

  Cano, Stefan J ^a,b   Hobart, Jeremy C ^b,c   Hart, Paul E ^a   Korlipara, L V Prasad ^a   Schapira, Anthony H V ^a   Cooper, J Mark ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c DERRIFORD HOSPITAL   (United Kingdom)

Author keywords

Friedreich's ataxia; Health measurement; Psychometrics; Rating scale; Reliability; Validity

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BODY POSTURE; DISEASE SEVERITY; FEMALE; FRIEDREICH ATAXIA; GAIT; HUMAN; INTERNATIONAL COOPERATIVE ATAXIA RATING SCALE; KINETICS; MAJOR CLINICAL STUDY; MALE; OCULOMOTOR NERVE DISEASE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROCESS MODEL; PROFESSIONAL STANDARD; PSYCHOMETRY; RATING SCALE; RELIABILITY; SCHOOL CHILD; SPEECH DISORDER; VALIDATION STUDY; VOLUNTARY REPORTING; CHILD; COMPARATIVE STUDY; DISABILITY; HOSPITALIZATION; INTERNATIONAL COOPERATION; LEGAL ASPECT; METHODOLOGY; MIDDLE AGED; NEUROLOGIC EXAMINATION; PATHOPHYSIOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SICKNESS IMPACT PROFILE; STANDARD; STATISTICAL MODEL;

ADOLESCENT; ADULT; CHILD; DISABILITY EVALUATION; FEMALE; FRIEDREICH ATAXIA; HUMANS; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; MODELS, STATISTICAL; NEUROLOGIC EXAMINATION; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE;

EID: 33644936037     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.20651     Document Type: Article

References (28)

1. Friedreich N. Uber degenerative atrophic der spinalen hinterstrange. Virchows Arch Pathol Anat 1863;26:391-419.
2. Campuzano V, Montermini L, Molto M, et al. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996;271:1423-1427.
3. Rustin P, von Kleist-Retzow J, Chantrel-Groussard K, et al. Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study. Lancet 1999;354:477-479.
4. Lodi R, Rajagopalan B, Hart P, et al. Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's Ataxia. Ann Neurol 2001;49:590-596.
5. Richardson D, Mouralian C, Ponka P, Becker E. Development of potential iron chelators for the treatment of Friedreich's ataxia: ligands that mobilize mitochondrial iron. Biochim Biophys Acta 2001;1536:133-140.
6. Russell S. Science, medicine, and the future: gene therapy. BMJ 1997;315:1289-1292.
7. Hobart J, Lamping D, Thompson A. Evaluating neurological outcome measures: the bare essentials. J Neurol Neurosurg Psychiatry 1996;60:127-130.
8. Hobart J, Lamping D, Freeman J, et al. Evidenced-based measurement - which disability scale for neurologic rehabilitation. Neurology 2001;57:639-644.
9. Trouillas P, Takayanagi T, Hallett M, Currier R, Subramony S, Wessel K. International cooperative ataxia rating scale for pharmacological assessment of the cerebellar syndrome. J Neurol Sci 1997;145:205-211.
10. Mori M, Adachi Y, Mori N, et al. Double-blind crossover study of branched-chain amino acid therapy in patients with spinocerebellar degeneration. J Neurol Sci 2002;195:149-152.
11. Hassin-Baer S, Korczyn A, Giladi N. An open trial of amantadine and buspirone for cerebellar ataxia: a disappointment. J Neural Transm 2000;107:1187-1189.
12. Gabsi S, Gouider-Khouja N, Belal S, et al. Effect of vitamin E supplementation in patients with ataxia with vitamin E deficiency. Eur J Neurol 2001;8:477-481.
13. Storey E, Tuck K, Hester R, Hughes A, Churchyard A. Inter-rater reliability of the International Cooperative Ataxia Rating Scale (ICARS). Mov Disord 2004;19:190-192.
14. Lodi R, Cooper J, Bradley J, et al. Deficit of in vivo mitochondrial ATP production in patients with Friedreich's ataxia. Proc Natl Acad Sci U S A 1999;96:11492-11495.
15. Likert R. A technique for the measurement of attitudes. Arch Psychol 1932;140:5-53.
16. Spector P. Summated rating scale construction: an introduction. In: Lewis-Beck M, editor. Quantitative applications in the social science. California: Sage; 1992.
17. Guttman L. Some necessary conditions for common factor analysis. Psychometrika 1954;19:149-161.
18. Nunnally J, Bernstein I. Psychometric theory. 3rd ed. New York: McGraw-Hill; 1994.
19. Ware J, Harris W, Gandek B, Rogers B, Reese P. MAP-R for Windows: multitrait/multi-item analysis program-revised user's guide version 1. Boston, MA: Health Assessment Lab; 1997.
20. McHorney C, Tarlov A. Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res 1995;4:293-307.
21. Hays R, Anderson R, Revicki D. Psychometric considerations in evaluating health-related quality of life measures. Qual Life Res 1993;2:441-449.
22. Cronbach L. Coefficient alpha and the internal structure of tests. Psychometrika 1951;16:297-334.
23. Cortina J. What is coefficient alpha? An examination of theory and applications. J App Psychol 1993;28:98-104.
24. Bohrnstedt G. Measurement, in handbook of survey research. New York: Academic Press; 1983.
25. Hobart J, Cano S, Thompson A. What sample sizes for reliability and validity studies? Qual Life Res 2002; 11:636.
26. Cano S, Warner T, Hobart J. What sample sizes for reliability and validity studies II: a prospective study. Qual Life Res 2003; 12:771.
27. Hobart J. Measuring disease impact in disabling neurological conditions: are patients' perspectives and scientific rigor compatible. Curr Opin Neurol 2002;15:721-724.
28. Cleary P. Subjective and objective measures of health: which is better when? J Health Serv Res Policy 1997;2:3-4.